BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Vitamin E
,
rs2476601
,
MYC
,
Metabolism of xenobiotics
,
Breast Cancer
,
Liver
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Rifampicin resistant tuberculosis
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
No genes found
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint arte…
Evaluation of biochip system in determining isoniazid and rifampicin resistances of mycobacterium tu…
Line probe assay for detection of rifampicin and isoniazid resistant tuberculosis in Pakistan.
Application of denaturing HPLC to rapidly identify rifampicin-resistant Mycobacterium tuberculosis i…
Molecular epidemiology of rifampicin mono-resistant Mycobacterium tuberculosis].
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifam…
Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparin…
Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis
Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifam…
Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ